溶化药物产品的过程验证:比较不同溶化产品的持续过程验证程序:海报在2025年PDA周发布
Abirami Natesh1, Denise Miller2
1Lyophilization Technology Inc., Ivyland, PA 18974, USA anatesh@lyo-t.com.
PDA journal of pharmaceutical science and technology
|August 1, 2025
概括
本研究探讨了有效的统计方法来监测冷化过程参数,确保药物产品质量的一致性和监管合规性. 它验证了在制药制造业中持续过程控制的强有力的方法.
科学领域:
- 制药制造业 制药制造业 制药制造业
- 过程分析技术 过程分析技术
- 通过设计的质量.
背景情况:
- 2011年FDA指南强调了整个产品生命周期的持续过程控制.
- 在冷化过程中监测关键过程参数 (CPPs),如温度和压力,具有挑战性.
- 在多产品设施中,用于过程变性分析的传统统计方法可能是低效的.
研究的目的:
- 评估用于监测冷化CPPs的特定统计方法的稳定性和效率.
- 为了提供一种更简单的方法来证明冷化过程中的控制状态.
- 确保医药制造业的一致的产品质量和监管合规性.
主要方法:
- 对各种分批冷产品的分析.
- 应用特定的统计方法来确定关键过程参数 (CPP) 的趋势.
- 与既定目标或已证明的可接受范围 (PAR) 进行实际工艺变化的比较.
主要成果:
- 选择的统计方法证明了对分析冷化数据的相对稳定性.
- 该研究确定了一种有效的方法,用于监测不同冷解产品的CPP.
- 持续监测冷化参数对于保持产品质量至关重要.
结论:
- 单一的,强大的统计方法可以有效地监测多产品设施中的冷化CPP.
- 实施有效的监测策略对于确保制药产品质量和遵守法规至关重要.
- 制造过程的持续重新评估和控制对于生命周期管理至关重要.
更多相关视频
相关概念视频
Data Validation
238
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
238
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
192
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
192
Sublimation
882
Sublimation is the direct transformation of a solid to a gaseous state. For instance, at standard pressure and room temperature, solid carbon dioxide sublimes to gaseous carbon dioxide. The phase diagram depicts the conditions required for sublimation. This process occurs at the solid-gas phase boundary and is not observed above the triple point of the substance. The reverse of sublimation is called deposition, where a gaseous substance condenses directly into a solid. Sublimation and...
882
Drug Administration and Therapy Phases: Overview
744
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
744


